Author:
Fernandes José A.,Abosede Olufunso,Galli Simona
Abstract
The reduction of cis-[CoIII(κ2N,N′-1,10-phenanthroline-5,6-dione)2Cl2]Cl into the neutral compound cis-[CoII(κ2N,N′-1,10-phenanthroline-5,6-dione)2Cl2] was observed during developmental studies of new antimalarial drugs. The crystal structure of cis-[CoII(κ2N,N′-1,10-phenanthroline-5,6-dione)2Cl2] was unveiled by powder X-ray diffraction studies (PXRD). PXRD details, unit cell parameters, and space group for cis-[CoII(κ2N,N′-1,10-phenanthroline-5,6-dione)2Cl2], C24H12Cl2CoN4O4, are reported [a = 41.4951 (13) Å, b = 8.2768 (2) Å, c = 12.4994 (3) Å, unit cell volume V = 4292.9 (2) Å3, Z = 8, and space group Fdd2]. Infrared spectroscopy features are also discussed.
Publisher
Cambridge University Press (CUP)
Subject
Condensed Matter Physics,Instrumentation,General Materials Science,Radiation
Reference39 articles.
1. Synthesis and Properties of Diamino-Substituted Dipyrido [3,2-a: 2′,3′-c]phenazine
2. World Health Organization (2016). “Malaria Fact Sheet (updated December 2016)” http://www.who.int/mediacentre/factsheets/fs094/en/.
3. World Health Organization (2015). “WHO Model List of Essential Medicines, 19th list (amended November 2015)” http://www.who.int/medicines/publications/essentialmedicines/en/.
4. Preparation of Co(dipy)2X2+ complexes (X- = chloride, bromide, iodide, nitrite) by controlled oxidative processes